See more : Galileo Mining Ltd (GAL.AX) Income Statement Analysis – Financial Results
Complete financial analysis of The Pennant Group, Inc. (PNTG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Pennant Group, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- UNIC Technology Corp. (5452.TWO) Income Statement Analysis – Financial Results
- STIF Société anonyme (ALSTI.PA) Income Statement Analysis – Financial Results
- Bentley Capital Limited (BEL.AX) Income Statement Analysis – Financial Results
- Vaxxinity, Inc. (VAXX) Income Statement Analysis – Financial Results
- CHO Pharma, Inc. (6586.TWO) Income Statement Analysis – Financial Results
The Pennant Group, Inc. (PNTG)
About The Pennant Group, Inc.
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 544.89M | 473.24M | 439.69M | 390.95M | 338.53M | 286.06M | 250.99M | 217.23M |
| Cost of Revenue | 477.86M | 414.66M | 393.96M | 336.07M | 293.92M | 243.62M | 218.58M | 188.94M |
| Gross Profit | 67.04M | 58.59M | 45.74M | 54.89M | 44.62M | 42.44M | 32.41M | 28.29M |
| Gross Profit Ratio | 12.30% | 12.38% | 10.40% | 14.04% | 13.18% | 14.84% | 12.91% | 13.02% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 36.67M | 33.98M | 36.26M | 31.30M | 35.14M | 18.84M | 14.46M | 12.45M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 36.67M | 33.98M | 36.26M | 31.30M | 35.14M | 18.84M | 14.46M | 12.45M |
| Other Expenses | 0.00 | 4.90M | 4.78M | 4.68M | 3.81M | 2.96M | 2.54M | 2.86M |
| Operating Expenses | 41.87M | 38.88M | 41.04M | 35.97M | 38.95M | 21.81M | 17.01M | 15.30M |
| Cost & Expenses | 519.72M | 453.54M | 435.00M | 372.04M | 332.86M | 265.43M | 235.59M | 204.24M |
| Interest Income | 0.00 | 3.82M | 1.94M | 1.24M | 410.00K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 5.92M | 3.82M | 1.94M | 1.24M | 410.00K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 5.13M | 4.90M | 4.78M | 4.68M | 4.03M | 2.96M | 2.54M | 2.86M |
| EBITDA | 30.64M | 24.60M | 9.46M | 23.82M | 9.48M | 23.60M | 17.95M | 15.84M |
| EBITDA Ratio | 5.62% | 5.19% | 2.15% | 6.09% | 2.80% | 8.25% | 7.15% | 7.29% |
| Operating Income | 25.17M | 19.67M | 4.70M | 18.92M | 5.67M | 20.63M | 15.40M | 12.98M |
| Operating Income Ratio | 4.62% | 4.16% | 1.07% | 4.84% | 1.67% | 7.21% | 6.14% | 5.98% |
| Total Other Income/Expenses | -5.59M | -3.85M | -1.97M | -1.01M | -410.00K | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 19.58M | 8.89M | 2.73M | 17.90M | 5.26M | 20.63M | 15.40M | 12.98M |
| Income Before Tax Ratio | 3.59% | 1.88% | 0.62% | 4.58% | 1.55% | 7.21% | 6.14% | 5.98% |
| Income Tax Expense | 5.67M | 1.65M | 582.00K | 2.35M | 2.09M | 4.35M | 5.38M | 5.07M |
| Net Income | 13.38M | 6.64M | 2.15M | 15.74M | 2.55M | 15.68M | 9.87M | 7.89M |
| Net Income Ratio | 2.46% | 1.40% | 0.49% | 4.03% | 0.75% | 5.48% | 3.93% | 3.63% |
| EPS | 0.45 | 0.23 | 0.08 | 0.56 | 0.09 | 0.56 | 0.35 | 0.28 |
| EPS Diluted | 0.44 | 0.22 | 0.07 | 0.52 | 0.09 | 0.56 | 0.35 | 0.28 |
| Weighted Avg Shares Out | 29.86M | 29.06M | 28.41M | 28.03M | 27.84M | 27.83M | 27.83M | 28.00M |
| Weighted Avg Shares Out (Dil) | 30.19M | 30.16M | 30.64M | 30.23M | 29.59M | 28.00M | 28.00M | 28.00M |
The Pennant Group, Inc. (PNTG) Q1 2024 Earnings Call Transcript
Top 5 Outpatient and Home Healthcare Stocks for Solid Returns
Compared to Estimates, The Pennant Group (PNTG) Q1 Earnings: A Look at Key Metrics
The Pennant Group, Inc. (PNTG) Tops Q1 Earnings and Revenue Estimates
Pennant Reports First Quarter 2024 Results
Pennant Acquires Senior Living Community in Idaho
Pennant Acquires Utah Home Health and Hospice Provider
Pennant Announces First Quarter 2024 Earnings Release and Call
What Makes The Pennant Group, Inc. (PNTG) a Strong Momentum Stock: Buy Now?
Pennant Group to Participate in the 2024 Oppenheimer Healthcare MedTech & Services Conference
Source: https://incomestatements.info
Category: Stock Reports